Literature DB >> 28464697

Assessment of the Procoagulant Activity of Microparticles and the Protein Z System in Patients Undergoing Off-Pump Coronary Artery Bypass Surgery.

Artur Słomka1, Aleksandra Piekuś2, Mariusz Kowalewski2, Wojciech Pawliszak2, Lech Anisimowicz2, Ewa Żekanowska1.   

Abstract

To understand the coagulation changes after off-pump coronary artery bypass (OPCAB) surgery, we evaluated the procoagulant activity of microparticles (MPs) and microparticles exposing tissue factor (MPs-TF), together with the levels of total tissue factor (TF), protein Z (PZ), protein Z-dependent protease inhibitor (ZPI), and factor X (FX) before (first day) and 1 week after surgery (seventh day) in plasma samples from 30 patients. Twenty healthy controls were also included. Compared to the controls, patients scheduled for surgery had significantly higher MPs-TF procoagulant activity and lower TF levels ( P = .0006, P = .02, respectively). In the whole cohort, median procoagulant activity of MPs-TF and median levels of TF and ZPI were significantly lower ( P = .02, P = .0003, and P = .004, respectively), while median levels of PZ and FX were significantly higher ( P = .02 and P = .002, respectively) on the seventh day compared to the first day. Our results suggest that OPCAB surgery has a significant effect on the procoagulant activity of MPs-TF and the PZ system.

Entities:  

Keywords:  off-pump coronary artery bypass surgery; protein Z; protein Z-dependent protease inhibitor; tissue factor–bearing microparticles

Mesh:

Substances:

Year:  2017        PMID: 28464697     DOI: 10.1177/0003319717706616

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  6 in total

Review 1.  Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation?

Authors:  Artur Słomka; Sabine Katharina Urban; Veronika Lukacs-Kornek; Ewa Żekanowska; Miroslaw Kornek
Journal:  Front Immunol       Date:  2018-12-13       Impact factor: 7.561

2.  Targeted metabolomic analysis of plasma metabolites in patients with coronary heart disease in southern China.

Authors:  Zhixiong Zhong; Jing Liu; Qifeng Zhang; Wei Zhong; Bin Li; Cunren Li; Zhidong Liu; Min Yang; Pingsen Zhao
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

Review 3.  Extracellular Vesicles in Comorbidities Associated with Ischaemic Heart Disease: Focus on Sex, an Overlooked Factor.

Authors:  Claudia Penna; Saveria Femminò; Giuseppe Alloatti; Maria F Brizzi; Tommaso Angelone; Pasquale Pagliaro
Journal:  J Clin Med       Date:  2021-01-17       Impact factor: 4.241

Review 4.  Clinical Application of Melatonin in the Treatment of Cardiovascular Diseases: Current Evidence and New Insights into the Cardioprotective and Cardiotherapeutic Properties.

Authors:  Mohammad Hossein Pourhanifeh; Ehsan Dehdashtian; Azam Hosseinzadeh; Seyed Hashem Sezavar; Saeed Mehrzadi
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-14       Impact factor: 3.727

5.  Association of smoking with postoperative atrial fibrillation in patients with cardiac surgery: A PRISMA-compliant article.

Authors:  Qin Wan; Siyuan Li; Jian Hu
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

Review 6.  Potential Beneficial Effects of Vitamin D in Coronary Artery Disease.

Authors:  Christian Legarth; Daniela Grimm; Marcus Krüger; Manfred Infanger; Markus Wehland
Journal:  Nutrients       Date:  2019-12-30       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.